Part,  Chapter, Paragraph

 1   II,     5.  2.  4|      in the standardization of laboratory assays. Beyond that, prevalence,
 2   II,     5.  3.  2|       both epidemiological and laboratory research and disseminates
 3   II,     5.  5.  3|       storage of the clinical, laboratory and imaging data of each
 4   II,     5. 10.  2|                Central Science Laboratory (CSL)~htt n/~Informall~http k/~
 5   II,     5. 11.  6|       between epidemiology and laboratory research to ensure that
 6   II,     5. 11.  6|        research to ensure that laboratory research priorities are
 7   II,     6.  3.  1|        often discovered by the laboratory in asymptomatic patients
 8   II,     6.  3.  1|  implications. One is that the laboratory capabilities of the Member
 9   II,     6.  3.  4|         improving EU influenza laboratory capacity.~ ~ ~ ~
10   II,     6.  3.  4|   contaminated milk or through laboratory contamination. Only 10%
11   II,     6.  3.  4|  resistance and to better link laboratory results with epidemiological
12   II,     6.  3.  6|      be noted that methods for laboratory diagnosis have really been
13   II,     6.  3.  6|        system should integrate laboratory data, in particular from
14   II,     6.  3.  7|        factors and standardise laboratory methods.~· Diseases imported
15   II,     6.  3.  7|   important to have sufficient laboratory capacity for rapid diagnoses
16   II,     6.  3.  7|        is available to protect laboratory personnel routinely working
17   II,     6.  3.  7|     occupational, military and laboratory staff. B. anthracis has
18   II,     6.  4.  4| assessment, as well as work on laboratory issues and sampling, have
19  III,    10.  2.  1|  combining epidemiological and laboratory methods in order to expand
20  III,    10.  2.  5|      shown to be neurotoxic in laboratory models. The toxic effects
21  III,    10.  3.  2|      shown to be neurotoxic in laboratory models. The toxic effects
22  III,    10.  3.  3|      be noted that methods for laboratory diagnosis have really been
23  III,    10.  3.  3|   contaminated milk or through laboratory contamination. Legionnaires’
24  III,    10.  4.  1|       those particles that, in laboratory trials, show the highest
25  III,    10.  4.  2|       of a Community reference laboratory, national reference laboratories
26  III,    10.  4.  2|   modified microorganism, e.g. laboratory research (in a confined
27  III,    10.  4.  2|    interest; (c) that adequate laboratory capacity for testing and
28   IV,    11.  1.  5|    dieticians, biochemists and laboratory scientist. Medical information